Introduction
Retinoic Acid (RA) and related vitamin A derivatives (retinoids) exert profound eects on many biological processes, including embryonic pattern formation, cell growth and dierentiation (De Luca, 1991; Gudas, 1992) . Various retinoids have been shown to modulate growth and dierentiation of a number of human cancers (reviewed in Gudas et al., 1994) , or in leukemias such as acute promyelocytic leukemia (Chomienne et al., 1991) . Originating in neural crest cells of developing sympathetic nervous system, neuroblastoma (NB) is a common solid tumor of childhood with poor prognosis, which sometimes spontaneously dierentiates in patients (Evans et al., 1971) . RA along with other retinoids has been demonstrated to be eective in the dierentiation and inhibition of the growth of NB cell lines in vitro (Sidell, 1982; Sidell et al., 1983; Reynolds et al., 1994) , with concomitant regulation of homeobox, thrombospondin and laminin genes (Castle et al., 1992; Manohar et al., 1996) . Subsequent clinical trials with 13-cis RA have shown to be of some but not complete eect (Finklestein et al., 1992; Smith et al., 1992; Villablanca et al., 1995) .
Investigations of the RA-signaling pathways involved in growth and dierentiation of normal and malignant neuronal cells may provide insights to achieve maximal therapeutic ecacy. RA controls target gene transcription through nuclear receptors which belong to the steroid/thyroid hormone nuclear receptor superfamily, RARs (RARa, b and g) and RXRs (RXRa, b and g) (reviewed in Leid et al., 1992; Mangelsdorf and Evans, 1995) . RARs and RXRs act through direct association with speci®c DNA sequences (RA-response elements or RAREs) which consist of a direct repeat of PuG(G/ T)TCA motifs with 1 ± 5 bp spacing (DR1 to DR5) (Mader et al., 1993; Mangelsdorf and Evans, 1995) . These dierent RAREs, present in the promoter region of target genes, dictate in a given tissue the mode of receptor binding (hetero or homodimers), the type of receptors involved and consequently, the speci®c retinoid-receptor ligand(s) eective for signaling.
RA-receptor genes are dierentially expressed during embryonic development and in adult tissues. Thus RARa is ubiquitous having been found in all tissues and cells examined, while RARb shows more restricted pattern: for example expression is high in brain and heart but undetectable in muscle and intestine (De The et al., 1989; Rees et al., 1989) . In mouse embryos, in situ hybridization studies have demonstrated that neural crest cells abundantly express RARa, and RARb; RARg expression is spatio-temporally restricted (Ruberte et al., 1991) . Concerning the RXRs receptors, studies performed in fetal neural tissues reported that RXRb is the most predominant, whereas RXRa is rarely found and RXRg absent (to the exception of the basal ganglia) (Mangelsdorf et al., 1992) . Human NB tumor cells express all three RARs isoforms, although at various levels (Lovat et al., 1993; Marshall et al., 1993; Li et al., 1994; Wuarin et al., 1994; Redfern et al., 1994) and of the RXRs, RXRb was reported to be predominant in one NB cell line (Plum and Clagett-Dame, 1995) .
However, to what extent mRNA levels determine protein concentrations and in¯uence the nature of functional heterodimers is unknown. In an eort to study RA signaling pathways, LA-N-5 and SH-SY5Y, two NB cell lines which have been shown to be sensitive to RA (Sidell et al., 1983; Marshall et al., 1993) , were studied to determine the constitutive expression of RARs (a, b, g) and RXRs (a, b, g), their modulation and capacity to bind RARE and con®rm in vivo their response to receptor speci®c agonists.
Results

Dierential constitutive expression of RARs and RXRs in LA-N-5 and SH-SY5Y cell lines
We analysed the expression of RARa, b, g and RXR a, b, g genes by Northern blot analysis. RARa mRNAs were constitutively expressed in both cell lines as two transcripts of 3.5 and 2.5 kb ( Figure 1a , lanes 1). RARb mRNAs were undetectable, and RARg mRNAs were either undetectable in LA-N-5 cells or barely seen in SH-SY5Y cells as a single 3.0 kb transcript. For genes of the RXR group, RXRb was weakly detected as a 2.8 kb transcript (Figure 1b) and RXRa expression evidenced only by RT ± PCR (data not shown).
Western blotting with anti-RARs or anti-RXRs antibodies were used to study protein expression in nuclear extracts of LA-N-5 and SH-SY5Y cell lines. RARa was easily detected as a 55 kDa protein, while RARb was not seen and RXRa barely detected ( Figure  2a , lanes 1, 3 and data not shown), con®rming mRNA studies.
Eects of RA, alone or in combination with IFNa, on growth and morphologic dierentiation in LA-N-5 and SH-SY5Y cell lines RA-mediated growth inhibition and morphologic dierentiation with respect of long neurite formation were assessed in LA-N-5 and SH-SY5Y cell lines. The ability of IFNa (100 U/ml) to potentiate RA-ecacy was also tested, since IFNa has been reported to enhance RA-induced dierentiation and to decrease cell growth in some NB cell lines (Higuchi et al., 1991; Rosolen et al., 1992) .
In both cell lines, RA induced a growth inhibition after 7 days (42%+19 for LA-N-5, and 44%+7 for SH-SY5Y) ( Figure 3a ) and induced morphological changes with formation of long neurites (Figure 3b , a to d), as previously reported (Sidell et al., 1983; Marshall et al., 1993) . These changes were already noticeable after 3 days of treatment and were much more marked by day 7. Treatment with IFNa alone (100 U/ml) did not result in signi®cant growth inhibition (12%+17 for LA-N-5 and 19%+3 for SH-SY5Y) (Figure 1a ) or morphological changes. In LA-N-5 and SH-SY5Y cell lines showed respectively a 2.8-and 1.9-fold increase in RARa mRNAs levels after 24 h incubation with RA. Interestingly, the increase was both delayed and transient, being discernible after 1 h incubation, with return to basal levels within 48 h ( Figure 1 , lane 2). This increase concerned both the two 3.5 and 2.5 kb transcripts. In contrast, a dramatic, more prolonged increase in RARb levels was detected in both cell lines after 24 Immunoblotting analysis on nuclear extracts con®rmed the up-regulation of both RARa and RARb upon RA treatment. RARb induction after 48 h treatment was dramatic in both cell lines, suggesting that protein levels re¯ect mRNA modulation. Induction of RARa levels was weak in SH-SY5Y (1.6-fold) ( Figure 2a ) and evident in LA-N-5 (2.9-fold) ( Figure  2b ). No signi®cant modulation of RXR protein levels were noted (data not shown).
RA-signaling pathways in NB cell lines
To further determine functionality of receptors in RAsensitive NB cells, we performed electrophoresis mobility shift assays (EMSA) with LA-N-5 nuclear extracts, after incubation with a 32 P-labeled DR5 oligodeoxynucleotide probe. Two major speci®c nuclear complexes (A1 and A2), and one minor one (A3) were detectable ( Figure 4a, lanes 1, 3) and were abolished when incubated with excess of unlabeled DR5 ( Figure 4a, lane 2) . No other speci®c binding complexes were observed after RA treatment, but A1, A2 and A3 complexes were signi®cantly enhanced ( Figure 4a, lane 7) . Experiments with speci®c antiRARs and anti-RXRs monoclonal antibodies allowed to further analyse the partners of these nuclear complexes. First, incubation with an anti-pan-RXR monoclonal antibody showed a complete shift of the three complexes suggesting that all of them involved an RXR partner (Figure 4a, lanes 4, 8) . Second, incubation with an anti-RARb reduced the formation of only the A1 complex in control cells, and produced a speci®c shifted complex upon RA treatment ( Figure  4b ). Third, anti-RXRa antibody induced disappearance of the A1 complex with a speci®c shifted complex, best seen after RA-treatment (Figure 4a , lanes 5, 9). Incubation with both anti-RARb and RXRa monoclonal antibodies resulted in a speci®c double-shifted complex and reduced binding of A1 (Figure 4c , lane 4) indicating that in NB cells, RARb binds to DR5-elements as a heterodimer with RXRa. Anti-RARa antibodes speci®cally reduced the formation of the A1 (Figure 4, lanes 6, 10) . These data indicate that nuclear extracts of NB cells which speci®cally interact with the RARE from the RARb promoter contain at least RARa and b and RXRa.
Treatment of LA-N-5 cells with RAR and RXR speci®c agonists
To support the hypothesis that both RARa and RARb may participate in RA's signaling pathways in NB, cells were cultured for ten days in the presence of speci®c RARa (10 76 M RA were used as positive and negative controls (Figure 5a and b Figure 5d ).
A synergistic eect was however obtained when the RXRa agonist was associated to either RARa or RARb agonists (Table 1, Figure 5e and f). Thus dierentiation induction by an RARa agonist alone, and of the combination of either RARa or RARb agonists with an RXRa agonist was similar to or indeed superior all-trans RA 10 76 alone.
Discussion
This study determined novel features of RARa and RARb pathways in neuroblastoma (NB). During RAinduced dierentiation of NB cell lines, RARa and RARb are induced both at the mRNA and protein levels. Gel retardation assays con®rmed the presence of an RXRa/RARb heterodimer and of RARa in a speci®c DR5-RARE bound nuclear extract. Treatment with speci®c RAR and RXR agonists further demonstrates that both RARa and RARb pathways can separately induce morphological dierentiation of NB cells. In our study, the RA-induced increase in RARa mRNA and the ecacy of the RARa agonist alone to trigger morphological dierentiation of LA-N-5 cells suggest the participation of RARa in RA-induced neuronal dierentiation. Interestingly, low RARa expressions have been associated to bad prognosis in NBs (Marshall et al., 1993) . In the light of the present results low RARa expression in NB tumors may re¯ect a speci®c stage of tumor dierentiation and in¯uence therapeutic ecacy. RARa has previously been implicated in the dierentiation of human tissues. In hematopoietic cells, where RARa is preferentially expressed, alteration of the RARa receptor through the t(15;17) and t(11;17) translocations has been linked to blockage of dierentiation in hematopoietic cells (Grignagni et al., 1993; Rousselot et al., 1994) and to leukemogenesis (de TheÂ et al., 1990; Chen et al., 1994) . The most compelling evidence for the role of RARa in dierentiation programmes was provided by studies of HL-60 cells which are resistant to RA and harbour a mutant RARa; transfection using normal RARa expression vectors was found to restore the differentiation response to RA (Collins et al., 1990) . This was further stressed by the superior ecacy of RARa speci®c agonists to induce dierentiation in APL and HL-60 cells (Calabresse et al., 1990; Chen et al., 1996) . RA-treatment is known to increase RARa mRNA in acute promyelocytic leukemic cells (Chomienne et al., 1991) and in RA-sensitive NB cell lines (Lovat et al., 1993; Li et al., 1994; Wuarin et al., 1994; Redfern et al., 1994) . These up-regulations are likely RA-induced as RARa2 gene promoters are known to have a RARE motif (Leroy et al., 1991) . Furthermore, this study brings evidence that RARb may also be implicated in RA signaling pathways leading to dierentiation. This is clearly evidenced by the identi®cation of an RXRa-RARb functional heterodimer in EMSA studies and the striking ecacy of the association of RARb and RXRa speci®c agonists to induce dierentiation. Synergistic actions of selective RAR and RXR agonists have recently been reported in P19 and F9 cells and in APL cells (Chen et al., 1996) . This has suggested that in the heterodimer, both RAR and RXR may activate transcription, although cooperation between independent events induced by RAR and RXR ligands could not be ruled out. RARb has been less clearly implicated in dierentiation processes and oncogenesis than RARa. Nevertheless, absence of RARb expression is noted in small cell lung and ovarian cancers where deletion of chromosome 3 is frequent (Carney and de Leij, 1988) , and transgenic mice bearing an excess of a dysfunctional RARb isoform have increased lung tumors (Berard et al., 1994) . Interestingly, in NB cell lines, RARb is either decreased or absent and inversely correlated to the ampli®cation of N-myc (Li et al., 1994) , a clinical prognosis parameter of neuroblastomas (Brodeur and Nakagawara, 1992) . If indeed RARb participates in neuronal dierentiation, then absence of RARb expression in NB cells may be one of the events leading to the malignant process. lines (Lovat et al., 1993; Li et al., 1994; Wuarin et al., 1994; Redfern et al., 1994) .
This RA-induced transcription of both RARa and RARb, which has been shown to be critical in RAsensitivity of NB cells (Wuarin et al., 1994) , could either suggest that both RARa and RARb are needed in the dierentiation process of neuroblastoma cells on their own or that there is a threshold level of ligandactivated RARs which must be reached for ecient dierentiation. That both RARa and RARb pathways can separately induce morphological dierentiation argues in favor of the latter hypothesis. Functional redundancy has been reported in knock-out mice (Kastner et al., 1995) , and in RARg7/7 null F9 cells where over expression of RARa and RARb can clearly mediate the RA-induction of early target genes whose expression is abrogated in RARg7/7 cells . Yet, dierentiation and late gene modulation may not be completely restored strongly suggesting that dierent receptors may induce speci®c molecular events (Marshall et al., 1995) . The distinct ecacy of retinoid agonists in this study raises the possibility that target gene transactivation through RARa or RARb in NB cells must dier as only the RARa agonist was eective alone, RARb requiring the presence of the RXR agonist. As recently suggested, this would imply a direct control through the AF-2 domain of RARa in the RXR/RARa heterodimer and through the AF-2 domain of RXRa for the RXRa/ RARb heterodimer (Chen et al., 1996; Lala et al., 1996) . Thus dierential expression and also dierential biological function may account for the presence of various retinoic acid receptors in a given tissue.
As NB cell lines are thought to arise in neural crest cells, the preferential expression of RXRb we detect in LA-N-5 and SK-SY5Y cells is in agreement with the high levels of RXRb in fetal neural tissues (Mangelsdorf et al., 1992 ). Yet, only RXRa showed evidence of functional involvement in DR5-binding experiments, which may suggest that RXRa is more dedicated to RARE binding than RXRb.
Treatment of acute promyelocytic leukemia is the ®rst successful application of dierentiation therapy for malignant disease and eorts are being made to evaluate retinoic acid therapy in other cancers. Our results provide strong molecular basis for RA ecacy in neuroblastoma cell lines and further stress the interest of targeted therapy with speci®c ligands, which might extend the therapeutic use of retinoids and avoid RA's numerous side-eects.
Materials and methods
Cell cultures
The human neuroblastoma cell lines LA-N-5 (Sidell et al., 1983) , and SH-SY5Y (Ross et al., 1983) were kindly provided respectively by Dr Sidell (LA) and Muriel Rigolet (UCSF). Cells were grown in RPMI 1640 (Life Technology, Cergy-Pontoise, France), supplemented with 10% Fetal Calf Serum (Boehringer, Meylan, France), 2 mM Glutamine, 50 U/ml penicillin, 50 mg streptomycin and 1 mg/ml fungizone (Life Technology, Cergy-Pontoise, France). All-trans-RA (RA) and IFNa were kindly provided by Homan-Laroche Laboratories (Basel, Switzerland) . Speci®c agonists CD336 (RARa agonist), CD2314 (RARb agonist) and CD2809 (RXRa agonist) were kindly provided by B Shroot (CIRD Galderma, Sophia-Antipolis, France). The powdered retinoids were dissolved in dimethyl-sulfoxide at an initial stock concentration of 10 72 M, stored at 7208C, and further diluted in RPMI 1640 before use. For IFNa, the initial stock concentration of 10 4 unit/ml was stored at 7208C, and further diluted in RPMI 1640 before use. For growth and dierentiation assays, 400 000 cells were plated in 25 cm 2 culture¯asks, RA (5 10 76 M) or agonists (10 76 to 10 78 M) were added at day 1 of culture, and the media (with or without RA or speci®c agonists) was changed on day 4 as previously reported (Sidell, 1982) . Morphological dierentiation was (A) ligand binding properties of the agonists, (B) cell growth inhibition and morphological dierentiation induced by selective synthetic retinoids in LA-N-5 cells. The morphological dierentiation of the cells was evaluated on the tenth day with respect to long neurite formation, and denoted 0 (no eect when compared to control), +(intermediary eect), ++(eect similar to RA alone), or +++(eect greater than RA alone) assessed daily with a phase-contrast microscope, with respect of long neurites formation. Cells were harvested on the indicated day by trypsinization, and counted on a Malassez hematocytometer. Cell viability was checked by trypan blue exclusion. Cell counts were performed in triplicate, and results expressed as the mean+s.e.m.
Northern blot analysis, DNA probes and hybridization techniques
Con¯uent cells were treated for 1 h, 24 h or 48 h with RA (5 10 76 M), IFNa (100 U/ml) or both, and 30610 76 cells were collected and used for each extraction. RNA was extracted by the guanidium isothiocyanate method, precipitated through a CsCl gradient (Chirgwin et al., 1979) , and stored at 7708C until use. RNA (15 ± 20 mg) was denatured and electrophoresed on a 1% agaroseformaldehyde gel in formamide loading buer, and then transferred to a nitrocellulose ®lter (Hybond C, Amersham, Les Ulis, France). Filters of Northern transfers were hybridized with cDNA probes labeled by the Radprime DNA labeling system (Gibco, Life Technology, CergyPontoise, France) to speci®c activities of 10 9 c.p.m./mg. A rat glyceraldehyde-3-phosphate dehydrogenase probe was used to rehybridize the ®lters and normalize RNA expression. Prehybridizations and hybridizations were performed in solutions containing 6XSSC (16SSC=0.15 M sodium chloride, 0.15 M sodium citrate), 0.5% sodium dodecyl sulfate (SDS), 50% formamide, 56 Denhart's solution and 100 mg/ml Herring sperm DNA at 428C. The ®lters were then washed under stringent conditions in 26SSC, 0.1% SDS for 20 min at room temperature, and for another 5 min in 0.26SSC, 0.1% SDS at 428C. The ®lters were subjected to autoradiography using Kodak-Biomax ®lms for 7 days. Quantitative densitometry was performed with a scanning laser densitometry (Appligene, Illkirch, France).
RARa, RARb, RARg, RXRa and RXRg probes were obtained by EcoRI digestion from clones pSG5-RARa, p17-RARb (generous gifts from Dr De TheÂ ), pBS-RARg, pRS-XR3-1 and pSK-mRXRg (generous gifts from Drs Mangelsdorf and Evans). The RXRb probe was obtained by ECoRI ± SacI digestion from clone pBS-KS TR24-3 (generous gift from Dr Dihenzo).
Preparation of nuclear extracts
At dierent time intervals, cells were collected by trypsine-EDTA (Life Technology, Cergy-Pontoise, France) and washed twice with cold phosphate buer saline (PBS) containing 10 mM NaF, 1 mM levamisole, 1 mM benzamidine, 10 mM sodium metabisul®te. Pellets were gently resuspended on ice in 0.4 ml of buer A (20 mM HEPES, pH 8/5 mM MgCl 2 /0.5% Nonidet P-40/10 mM NaF/1 mM levamisole/1 mM benzamidine/10 mM sodium metabisul®te/ 0.1 mM phenylmethylsulfonyl¯uoride and 1% aprotinin). After centrifugation, the supernatant was kept at 7808C and used as cytoplasmic extracts. The pellet containing the nuclei was further extracted in 0.4 ml of buer B (10 mM HEPES, pH8/25% glycerol/5 mM MgCl 2 /0.1 mM CaCl 2 / 0.1 mM EDTA/0.1 mM EGTA/500 mM NaCl/10 mM Naf/0.5 spermidine/0.15 mM spermine/7 mM b-mercaptoethanol/1 mM levamisole/1 mM benzamidine/1 mM sodium metabisul®te/0.1 mM phenylmethylsulfonyl¯uoride and 1% aprotinin). The suspension was incubated for 15 min on ice and then centrifuged at 10 000 g for 15 min. The resulting supernatant was referred to as the nuclear extract and rapidly frozen at 7808C. Protein concentrations were determined with a BCA-protein assay kit (Pierce, Rockford, USA).
